- $28.44m
- $38.66m
- $283.22m
Annual income statement for Iqstel, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 44.9 | 64.7 | 93.2 | 145 | 283 |
| Cost of Revenue | |||||
| Gross Profit | 0.962 | 1.53 | 1.79 | 4.67 | 8.27 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 48.3 | 68.2 | 96.4 | 145 | 285 |
| Operating Profit | -3.37 | -3.51 | -3.19 | -0.316 | -1.32 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.7 | -3.86 | -5.87 | -0.219 | -4.79 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.7 | -3.86 | -5.87 | -0.219 | -5.18 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -6.57 | -3.84 | -5.97 | -0.763 | -5.99 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.57 | -3.84 | -5.97 | -1.58 | -6.62 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.1 | -0.024 | -0.036 | -0.008 | -0.033 |